Lav Biosciences Fund V, L.p. - Net Worth and Insider Trading

Lav Biosciences Fund V, L.p. Net Worth

The estimated net worth of Lav Biosciences Fund V, L.p. is at least $9 Million dollars as of 2024-06-21. Lav Biosciences Fund V, L.p. is the 10% Owner of Terns Pharmaceuticals Inc and owns about 1,286,698 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $9 Million. Details can be seen in Lav Biosciences Fund V, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lav Biosciences Fund V, L.p. has not made any transactions after 2022-11-23 and currently still holds the listed stock(s).

Transaction Summary of Lav Biosciences Fund V, L.p.

To

Lav Biosciences Fund V, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lav Biosciences Fund V, L.p. owns 1 companies in total, including Terns Pharmaceuticals Inc (TERN) .

Click here to see the complete history of Lav Biosciences Fund V, L.p.’s form 4 insider trades.

Insider Ownership Summary of Lav Biosciences Fund V, L.p.

Ticker Comapny Transaction Date Type of Owner
TERN Terns Pharmaceuticals Inc 2022-11-23 10 percent owner

Lav Biosciences Fund V, L.p. Latest Holdings Summary

Lav Biosciences Fund V, L.p. currently owns a total of 1 stock. Lav Biosciences Fund V, L.p. owns 1,286,698 shares of Terns Pharmaceuticals Inc (TERN) as of November 23, 2022, with a value of $9 Million.

Latest Holdings of Lav Biosciences Fund V, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TERN Terns Pharmaceuticals Inc 2022-11-23 1,286,698 7.21 9,277,093

Holding Weightings of Lav Biosciences Fund V, L.p.


Lav Biosciences Fund V, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Lav Biosciences Fund V, L.p. has made a total of 1 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Terns Pharmaceuticals Inc is the sale of 1,500,000 shares on November 23, 2022, which brought Lav Biosciences Fund V, L.p. around $8 Million.

Insider Trading History of Lav Biosciences Fund V, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lav Biosciences Fund V, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lav Biosciences Fund V, L.p. Ownership Network

Ownership Network List of Lav Biosciences Fund V, L.p.

No Data

Ownership Network Relation of Lav Biosciences Fund V, L.p.

Insider Network Chart

Lav Biosciences Fund V, L.p. Owned Company Details

What does Terns Pharmaceuticals Inc do?

Who are the key executives at Terns Pharmaceuticals Inc?

Lav Biosciences Fund V, L.p. is the 10 percent owner of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include Chief Financial Officer Mark J. Vignola , COO and General Counsel Seokho Bryan Yoon , and 10 percent owner Vivo Opportunity Fund Holdings, L.p. .

Terns Pharmaceuticals Inc (TERN) Insider Trades Summary

Over the past 18 months, Lav Biosciences Fund V, L.p. made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 15,531 shares made by Seokho Bryan Yoon , a net purchase of 15,531 shares made by Mark J. Vignola , and a net purchase of 337,957 shares made by Vivo Opportunity Fund Holdings, L.p. .

In summary, during the past 3 months, insiders sold 420,663 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 9,582 shares, with a net sale of 411,081 shares. During the past 18 months, 420,663 shares of Terns Pharmaceuticals Inc (TERN) were sold and 1,826,275 shares were bought by its insiders, resulting in a net purchase of 1,405,612 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Terns Pharmaceuticals Inc Insider Transactions

No Available Data

Lav Biosciences Fund V, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Lav Biosciences Fund V, L.p.. You might contact Lav Biosciences Fund V, L.p. via mailing address: C/o Estera Trust (cayman) Limited, 75 Fort Street, Po Box 1350, Grand Cayman E9 Ky1-1108.

Discussions on Lav Biosciences Fund V, L.p.

No discussions yet.